Cargando…

Rebound of relapses after discontinuation of rituximab in a patient with MOG-IgG1 positive highly relapsing optic neuritis: a case report

BACKGROUND: Myelin oligodendrocyte glycoprotein immunoglobulin G1 (MOG-IgG1)-associated disease is suggested as a separate disease entity distinct from multiple sclerosis and neuromyelitis optica spectrum disorder. Nonetheless, the optimal treatment regimen for preventing relapses in MOG-IgG1-associ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Seok-Jin, Kim, Boram, Lee, Haeng-Jin, Kim, Seong-Joon, Kim, Sung-Min, Sung, Jung-Joon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302456/ https://www.ncbi.nlm.nih.gov/pubmed/30577778 http://dx.doi.org/10.1186/s12883-018-1222-1

Ejemplares similares

Relapsing optic neuritis and meningoencephalitis in a child: case report of delayed diagnosis of MOG-IgG syndrome
por: Zhong, Xiaonan, et al.
Publicado: (2019)

MOG-expressing teratoma followed by MOG-IgG-positive optic neuritis
por: Wildemann, Brigitte, et al.
Publicado: (2020)

Optic neuritis of MOG-IgG-associated autoimmune disorders: a case report
por: Li, Tiantian, et al.
Publicado: (2021)

Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies
por: Lee, Haeng-Jin, et al.
Publicado: (2018)

Uveitis, optic neuritis and MOG
por: Gupta, Pranjal, et al.
Publicado: (2020)

MOG-IgG- versus AQP4-IgG-Positive Optic Neuritis in Thailand: Clinical Characteristics and Long-Term Visual Outcomes Comparison
por: Narongkhananukul, Chanomporn, et al.
Publicado: (2020)

MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder
por: dos Passos, Giordani Rodrigues, et al.
Publicado: (2018)

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients
por: Pache, Florence, et al.
Publicado: (2016)

Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort Study
por: Stiebel-Kalish, Hadas, et al.
Publicado: (2017)

AQP4-IgG and MOG-IgG Related Optic Neuritis—Prevalence, Optical Coherence Tomography Findings, and Visual Outcomes: A Systematic Review and Meta-Analysis
por: Filippatou, Angeliki G., et al.
Publicado: (2020)

Comparison of spontaneous brain activity revealed by regional homogeneity in AQP4-IgG neuromyelitis optica-optic neuritis versus MOG-IgG optic neuritis patients: a resting-state functional MRI study
por: Wang, Junqing, et al.
Publicado: (2017)

Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis
por: Boremalm, Malin, et al.
Publicado: (2021)

Efficacy for the Annual Relapse Rate after the Immunosuppressive Therapy in Patients Associated with Anti-AQP4 or Anti-MOG Antibody-Positive Optic Neuritis
por: Mori, Sotaro, et al.
Publicado: (2020)

Relapsing Ipsilateral Vestibular Neuritis
por: Emiliano De Schutter, Duilio, et al.
Publicado: (2017)

Regulatory T Cells Increase After rh-MOG Stimulation in Non-Relapsing but Decrease in Relapsing MOG Antibody-Associated Disease at Onset in Children
por: Horellou, Philippe, et al.
Publicado: (2021)

Serum IgG4 level during initial treatment as a predictor of relapse in IgG4-related disease
por: Choi, Su Jin, et al.
Publicado: (2023)

Treatment and Relapse Prevention of Typical and Atypical Optic Neuritis
por: Saitakis, George, et al.
Publicado: (2022)

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
por: Kim, Sung-Min, et al.
Publicado: (2015)

Recent developments in MOG-IgG associated neurological disorders
por: Hegen, Harald, et al.
Publicado: (2020)

Frequency of MOG-IgG in cerebrospinal fluid versus serum
por: Pace, Samuel, et al.
Publicado: (2022)

Peripherally derived macrophages as major phagocytes in MOG encephalomyelitis
por: Kwon, Young Nam, et al.
Publicado: (2019)

Myelin Oligodendrocyte Glycoprotein (MOG) Optic Neuritis: A Case Series
por: Nurul-Ain, Masnon, et al.
Publicado: (2021)

Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders
por: Asseyer, Susanna, et al.
Publicado: (2018)

HLA association in MOG-IgG– and AQP4-IgG–related disorders of the CNS in the Dutch population
por: Bruijstens, Arlette L., et al.
Publicado: (2020)

Brain Atrophy in Relapsing Optic Neuritis Is Associated With Crion Phenotype
por: Cantó, Laura Navarro, et al.
Publicado: (2019)

A multicenter comparison of MOG-IgG cell-based assays
por: Waters, Patrick J., et al.
Publicado: (2019)

Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel
por: Brill, Livnat, et al.
Publicado: (2021)

Characteristics of Optic Neuritis in South Korean Children and Adolescents: A Retrospective Multicenter Study
por: Park, Kyung-Ah, et al.
Publicado: (2022)

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
por: Ramanathan, Sudarshini, et al.
Publicado: (2018)

Retinal Layer Thinning After Optic Neuritis Is Associated With Future Relapse Remission in Relapsing Multiple Sclerosis
por: Bsteh, Gabriel, et al.
Publicado: (2022)

Positive Predictive Value of MOG-IgG for Clinically Defined MOG-AD Within a Real-World Cohort
por: Manzano, Giovanna S., et al.
Publicado: (2022)

A case report of neurosyphilis coexisting with a positive MOG antibody manifested as optic neuritis
por: Shi, Min, et al.
Publicado: (2023)

Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease
por: Cobo-Calvo, Alvaro, et al.
Publicado: (2019)

Predictors of relapse in MOG antibody associated disease: a cohort study
por: Huda, Saif, et al.
Publicado: (2021)

Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis
por: Chalmoukou, Konstantina, et al.
Publicado: (2015)

Baseline Brain Activity Changes in Patients With Single and Relapsing Optic Neuritis
por: Ren, Zhuoqiong, et al.
Publicado: (2018)

Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain
por: Saadoun, Samira, et al.
Publicado: (2014)

Seroprevalence and clinical phenotype of MOG-IgG-associated disorders in Sri Lanka
por: Senanayake, Bimsara, et al.
Publicado: (2019)

Serum MOG-IgG in children meeting multiple sclerosis diagnostic criteria
por: Fadda, Giulia, et al.
Publicado: (2022)

Use of lenalidomide in the management of relapsed or refractory multiple myeloma: expert recommendations in Korea
por: Kim, Hyo Jung, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lv09ks25588qpfharbnnepainc